Catalent
CTLT
#1583
Rank
ยฃ8.31 B
Marketcap
ยฃ45.80
Share price
-0.35%
Change (1 day)
20.23%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Net assets

Net assets on the balance sheet as of June 2024 : ยฃ2.74 B

According to Catalent's latest financial reports the company has ยฃ2.74 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Catalent - Net assets on balance sheet (from 2013 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$ยฃ3.62 B-7.49%
2022-06-30$ยฃ3.92 B26.61%
2021-06-30$ยฃ3.09 B9.35%
2020-06-30$ยฃ2.83 B57.12%
2019-06-30$ยฃ1.80 B119.09%
2018-06-30$ยฃ0.82 B47.91%
2017-06-30$ยฃ0.55 B17.53%
2016-06-30$ยฃ0.47 B17.61%
2015-06-30$ยฃ0.40 B-284.37%
2014-06-30$-ยฃ0.22 B-19.08%
2013-06-30$-ยฃ0.27 B20.66%
2012-06-30$-ยฃ0.23 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ0.72 B-73.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.13 B-104.55%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.86 B 4.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ54.74 M-98.01%๐Ÿ‡บ๐Ÿ‡ธ USA